GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (FRA:OL0) » Definitions » Total Equity

Devyser Diagnostics AB (FRA:OL0) Total Equity : €30.74 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Devyser Diagnostics AB Total Equity?

Devyser Diagnostics AB's total equity for the quarter that ended in Sep. 2024 was €30.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Devyser Diagnostics AB Total Equity Historical Data

The historical data trend for Devyser Diagnostics AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devyser Diagnostics AB Total Equity Chart

Devyser Diagnostics AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial 3.53 3.03 40.57 39.24 34.43

Devyser Diagnostics AB Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.65 34.43 33.09 32.59 30.74

Devyser Diagnostics AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Devyser Diagnostics AB's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=45.601-11.175
=34.43

Devyser Diagnostics AB's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=40.774-10.033
=30.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Devyser Diagnostics AB Total Equity Related Terms

Thank you for viewing the detailed overview of Devyser Diagnostics AB's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Devyser Diagnostics AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Devyser Diagnostics AB (FRA:OL0) » Definitions » Total Equity
Comparable Companies
OSTO:SENZA OSTO:AROC NGM:ATANA XSAT:ALPH OSTO:PROGEN XSAT:SPERM OSTO:IMMNOV XSAT:GEAN XSAT:CALMA B TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN
Traded in Other Exchanges
DVYSR:Sweden
Address
Instrumentvagen 19, Hagersten, SWE, 126 53
Website
https://www.devyser.com
Devyser Diagnostics AB develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. The products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up.

Devyser Diagnostics AB Headlines

No Headlines